DSM Announces Start of Avansya

HEERLEN, Netherlands, March 1, 2019 /PRNewswire/ --

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announced the establishment of Avansya V.O.F.The 50:50 joint venture isa partnership betweenCargill andDSM. Both parties announced their intention to establish this joint ventureon November 8, 2018 subject to regulatory approvals. Avansya will produce zero-calorie, great-tasting sweeteners through fermentationand will be headquartered at the Biotech Campus Delft (Netherlands).

     (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )

As food and beverage producers look to significantly reduce calories in their offerings to consumers, they are in need of non-artificial, zero-calorie, great-tasting sweetener options. Avansya will produce highly sought-after, sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through fermentation, giving food and beverage manufacturers an even more scalable, sustainable and low cost-in-use solution than if these same molecules were extracted from the stevia leaf. Avansya's sweeteners will be produced at a fermentation facility at the Cargill site in Blair and Avansya will market its sweeteners under the EverSweet™ brand.

Oscar Goddijn will serve as CEO for Avansya and Andrew Ohmes as VP Marketing & Sales. Biotechnologist Goddijn has been with DSM for more than 16 years, most recently as Vice President Stevia & Sugar Reduction Products. Ohmes continues to be globally responsible for high intensity sweeteners at Cargill, where he has built his career since 2000, in addition to his VP Marketing & Sales role for Avansya.

About DSM - Bright Science. Brighter Living.™ 

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.

Forward-looking statements 

This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

https://www.dsm.com

For more information:
DSM Corporate Communications
Herman Betten/Stephen Hufton
tel. +31(0)45-5782420       
e-mail media.contacts@dsm.com

DSM Investor Relations
Dave Huizing
tel. +31(0)45-5782864
e-mail investor.relations@dsm.com

    PRN NLD